Author/Authors :
Ornstein , Moshe C. Department of Hematology and Medical Oncology - Cleveland Clinic Taussig Cancer Institute - Cleveland - Ohio, USA , Sheng, Iris Y. Department of Hematology and Medical Oncology - Cleveland Clinic Taussig Cancer Institute - Cleveland - Ohio, USA , Kruse, Megan Department of Hematology and Medical Oncology - Cleveland Clinic Taussig Cancer Institute - Cleveland - Ohio, USA , Leininger, Kathryn M. Department of Hematology and Medical Oncology - Cleveland Clinic Taussig Cancer Institute - Cleveland - Ohio, USA
Abstract :
Synchronous tumors are defined as two tumors arising concurrently or within six months of each other. Reports of synchronousRCC and breast cancer are limited to nonmetastatic renal cell carcinoma (RCC) and hormone receptor-positive infiltrativeductal carcinoma. We present thefirst case of synchronous metastatic renal cell carcinoma and metastatic triple-negative breastcancer, managed with a novel combination of immunotherapy and chemotherapy
Keywords :
Tailoring Immunotherapy Treatment , Synchronous Renal Cell Carcinoma (RCC) , Triple-Negative Breast Cancer (TNBC) , SQSTM1-RET
